These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39150359)

  • 41. Evaluation of Cheek Edema in an Infant Reveals Langerhans Cell Histiocytosis.
    Asimakopoulos AD; Panosetti E; Papoudou-Bai A; Sioka C
    Ethiop J Health Sci; 2022 Jan; 32(1):217-220. PubMed ID: 35250234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of brain F-18 FDG PET/MRI with PET/CT imaging in pediatric patients.
    Sager G; Akgun E; Abuqbeitah M; Uslu L; Asa S; Akgun MY; Beytur F; Baydili KN; Sager S
    Clin Neurol Neurosurg; 2021 Jul; 206():106669. PubMed ID: 33984753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Necrobiotic Xanthogranuloma on 18F-FDG PET/CT.
    Eltilib M; Fenner J; Saramago I; Oldan J
    Clin Nucl Med; 2020 Dec; 45(12):967-969. PubMed ID: 32969908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PET/CT Showing a Case of Langerhans Cell Histiocytosis Involving the Pleura.
    Tang P; Zhou Y; Tian R
    Clin Nucl Med; 2023 Jan; 48(1):98-99. PubMed ID: 36469071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PET-CT in pediatric Langerhans cell histiocytosis.
    Kaste SC; Rodriguez-Galindo C; McCarville ME; Shulkin BL
    Pediatr Radiol; 2007 Jul; 37(7):615-22. PubMed ID: 17564738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging.
    Kaneuchi Y; Hakozaki M; Yamada H; Hasegawa O; Tajino T; Konno S
    Hell J Nucl Med; 2016; 19(1):46-8. PubMed ID: 26929940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from
    Schmidkonz C; Krumbholz M; Atzinger A; Cordes M; Goetz TI; Prante O; Ritt P; Schaefer C; Agaimy A; Hartmann W; Rössig C; Fröhlich B; Bäuerle T; Dirksen U; Kuwert T; Metzler M
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1564-1575. PubMed ID: 31853559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disseminated osteomyelitis or bone metastases of breast cancer: (18)F-FDG-PET/CT helps unravel an unusual presentation.
    Mandegaran R; Debard A; Alvarez M; Marchou B; Massip P; Wagner T
    Ann Nucl Med; 2014 Feb; 28(2):167-71. PubMed ID: 24203488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous Detection of 2 Types of Malignancies in a Pediatric Patient on FDG PET/CT Led to Diagnosis of Li-Fraumeni Syndrome.
    Kan Y; Si Y; Wang W; Yang J
    Clin Nucl Med; 2022 Oct; 47(10):912-913. PubMed ID: 35543639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. False-positive PET/CT for lymphoma recurrence secondary to Langerhans cell histiocytosis.
    Fotos JS; Flemming DJ; Tulchinsky M
    Clin Nucl Med; 2011 Aug; 36(8):717-9. PubMed ID: 21716031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of 18F-FDG PET-CT for Detection of Active Disease in Acute Myeloid Leukemia.
    Elojeimy S; Luana Stanescu A; Parisi MT
    Clin Nucl Med; 2016 Mar; 41(3):e137-40. PubMed ID: 26402136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rare Presentation of Inflammatory Lung Disease and Subcutaneous Nodules on FDG PET/CT Scan: Brief Discussion of Differential Diagnoses.
    Doroudinia A; Karam MB; Yousefi F; Ghadimi N
    Clin Nucl Med; 2022 Mar; 47(3):e304-e305. PubMed ID: 35025810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solitary Adult Rib Langerhans Cell Histiocytosis Evaluated by 18F-FDG PET/CT.
    Wang Q; Yang S; Tang W; Liu H; Chen Y
    Clin Nucl Med; 2021 Sep; 46(9):756-758. PubMed ID: 33795592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utility of 18F-FDG PET/CT in diagnosis and management of mucormycosis.
    Liu Y; Wu H; Huang F; Fan Z; Xu B
    Clin Nucl Med; 2013 Sep; 38(9):e370-1. PubMed ID: 23531773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of
    Luo ZH; Lu PX; Qi WL; Liao FX; Jin AF; Zen QY
    Quant Imaging Med Surg; 2022 Jun; 12(6):3351-3363. PubMed ID: 35655814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report.
    Ren Y; Huang L; Han Y; Cui Z; Li J; Dong C; Liu J
    Medicine (Baltimore); 2019 Feb; 98(5):e14270. PubMed ID: 30702589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Superiority of
    Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 18F-FDG PET/CT findings in patients with Kikuchi disease.
    Kong E; Chun K; Hong Y; Hah J; Cho I
    Nuklearmedizin; 2013; 52(3):101-6. PubMed ID: 23681151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of
    Sevaslidou I; Papavasileiou P; Gavra M; Baka M; Polychronopoulou S; Gogou L
    Hell J Nucl Med; 2023; 26(3):215-218. PubMed ID: 38149775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.